ESR1 and breast cancer: Moreover, as the expression of ACSL4 is negatively regulated by estrogen and in turn regulates the levels of ERα, the presence of ACSL4 could be a prognostic factor for hormone resistance in ERα-positive breast cancer tissues that begin to express it.